These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 22116334)
1. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Chou DW; Wu SL; Lee CT; Tai FT; Yu WL Jpn J Infect Dis; 2011; 64(6):520-4. PubMed ID: 22116334 [TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. Chen FL; Wang GC; Teng SO; Ou TY; Yu FL; Lee WS J Microbiol Immunol Infect; 2013 Dec; 46(6):425-32. PubMed ID: 23022462 [TBL] [Abstract][Full Text] [Related]
3. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. Lin YT; Jeng YY; Lin ML; Yu KW; Wang FD; Liu CY J Microbiol Immunol Infect; 2010 Dec; 43(6):498-505. PubMed ID: 21195977 [TBL] [Abstract][Full Text] [Related]
4. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Lin PY; Chen HL; Huang CT; Su LH; Chiu CH Int J Antimicrob Agents; 2010 Nov; 36(5):436-40. PubMed ID: 20933186 [TBL] [Abstract][Full Text] [Related]
5. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Hsu MS; Liao CH; Huang YT; Liu CY; Yang CJ; Kao KL; Hsueh PR Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1271-8. PubMed ID: 21461847 [TBL] [Abstract][Full Text] [Related]
6. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148 [TBL] [Abstract][Full Text] [Related]
7. Chryseobacterium indologenes bacteremia in an infant. Douvoyiannis M; Kalyoussef S; Philip G; Mayers MM Int J Infect Dis; 2010 Jun; 14(6):e531-2. PubMed ID: 19729329 [TBL] [Abstract][Full Text] [Related]
8. [Sepsis caused by Chryseobacterium indologenes in a patient with hydrocephalus]. Ceylan A; Güdücüoğlu H; Akbayram S; Bektaş A; Berktaş M Mikrobiyol Bul; 2011 Oct; 45(4):735-40. PubMed ID: 22090305 [TBL] [Abstract][Full Text] [Related]
9. Chryseobacterium indologenes bacteraemia in a preterm baby. Sudharani V; ; Saxena NK Indian J Med Microbiol; 2011; 29(2):196-8. PubMed ID: 21654125 [No Abstract] [Full Text] [Related]
10. Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient. Shah S; Sarwar U; King EA; Lat A Transpl Infect Dis; 2012 Aug; 14(4):398-402. PubMed ID: 22283924 [TBL] [Abstract][Full Text] [Related]
11. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Sligl W; Taylor G; Brindley PG Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982 [TBL] [Abstract][Full Text] [Related]
12. A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy. Corbella M; Brandolini M; Cambieri P; Decembrino N; Pagani M; Bottazzi A; Muzzi A; Zecca M; Mariani B; Marone P New Microbiol; 2017 Jul; 40(3):223-225. PubMed ID: 28675244 [TBL] [Abstract][Full Text] [Related]
13. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. Christakis GB; Perlorentzou SP; Chalkiopoulou I; Athanasiou A; Legakis NJ J Clin Microbiol; 2005 Apr; 43(4):2021-3. PubMed ID: 15815050 [TBL] [Abstract][Full Text] [Related]
14. [Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation]. Kodama Y; Nishimura M; Nakashima K; Ito N; Fukano R; Okamura J; Inagaki J Rinsho Ketsueki; 2013 Mar; 54(3):305-10. PubMed ID: 23676648 [TBL] [Abstract][Full Text] [Related]
15. Noncatheter-related bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient. Baruah M; Lyngdoh C; Lyngdoh WV; Talukdar R Indian J Med Microbiol; 2016; 34(3):380-1. PubMed ID: 27514966 [TBL] [Abstract][Full Text] [Related]
16. Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality. Hung PP; Lin YH; Lin CF; Liu MF; Shi ZY J Microbiol Immunol Infect; 2008 Apr; 41(2):137-44. PubMed ID: 18473101 [TBL] [Abstract][Full Text] [Related]
17. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. Tsay RW; Lin LC; Chiou CS; Liao JC; Chen CH; Liu CE; Young TG J Microbiol Immunol Infect; 2005 Jun; 38(3):194-9. PubMed ID: 15986070 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit. Liao CH; Chang HT; Lai CC; Huang YT; Hsu MS; Liu CY; Yang CJ; Hsueh PR Diagn Microbiol Infect Dis; 2011 Jun; 70(2):260-6. PubMed ID: 21392926 [TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of Freitas EA; Ferreira WA; Filho RAAB; Oliveira CMC; Dhyani A; Silva LM; Fraiji NA; Ferreira CM Microb Drug Resist; 2019 Jun; 25(5):781-786. PubMed ID: 30585755 [No Abstract] [Full Text] [Related]
20. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]